Johnson & Johnson (JNJ)
XDUS
Real-time Data
06:00 AM
Day's Range
227.8552 wk Range
147.60Overview - JNJ - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
28.22B
P/E (Trailing)
‪20.83‬
PEG Ratio
‪-182.23‬
Price / Book
‪6.57‬
EV / EBITDA
‪0.80‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪67.87%‬
Operating Margin
‪35.62%‬
Return on Assets
‪13.45%‬
Return on Equity
‪32.87%‬
Ownership
Shares Outstanding
2.40B
Price stats
50-Day Avg
‪221.22‬
200-Day Avg
‪200.18‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - JNJ - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- JNJXDUSJohnson & Johnson+33.33%52-week change20.82P/E (Trailing)‪67.87%‬Profit Margin
- LLYXDUSEli Lilly and Company+43.08%52-week change46.79P/E (Trailing)‪83.04%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.50%52-week change-13.04P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+41.66%52-week change17.34P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+35.99%52-week change21.13P/E (Trailing)‪75.69%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+32.38%52-week change19.41P/E (Trailing)‪67.87%‬Profit Margin
- 7XPXDUSOrganon & Co.+31.76%52-week change16.18P/E (Trailing)‪53.29%‬Profit Margin
Profile Summary - JNJ - Johnson & Johnson
About
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
